Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2025 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of Service
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to The Report
Fundraising

OpenAI

OpenAI Raises $6.6B in Series C

2015
Founded
1500+
Employees
3180 18th Street, San Francisco, CA 94110
Updated October 2, 2025
2 min read

Quick Facts

OpenAI Raises $6.6B in Series C


OpenAI has successfully raised $6.6B in a Series C at a $157B valuation led by Thrive Capital, Microsoft, SoftBank, Nvidia, Khosla Ventures, Fidelity, MGX, Tiger Global.


Company Overview


OpenAI is a AI/ML company headquartered in 3180 18th Street, San Francisco, CA 94110, founded in 2015 with 1500+ employees.


AI research and deployment company


Fundraising Details


  • Amount Raised: $6.6B
  • Round Type: Series C
  • Valuation: $157B
  • Date: 2025-10-02
  • Investors: Thrive Capital, Microsoft, SoftBank, Nvidia, Khosla Ventures, Fidelity, MGX, Tiger Global

About OpenAI


AI research and deployment company The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 3180 18th Street, San Francisco, CA 94110
  • Founded: 2015
  • Team Size: 1500+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in OpenAI's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. OpenAI's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $157B valuation marks an important milestone for OpenAI, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, OpenAI is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-10-02. For more information about OpenAI, visit their headquarters at 3180 18th Street, San Francisco, CA 94110.

Topics

Fundraising(2912)AI/ML(481)Series C(291)OpenAI

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min readβ€’160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min readβ€’130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min readβ€’120 million